Ma, W., Wu, Y., Lin, X., Yang, L., & Huang, L. (2024, December). Amelioration of inflammatory bowel disease by Bifidobacterium animalis subsp. lactis XLTG11 in combination with mesalazine. Frontiers in Microbiology.
Chicago Style (17th ed.) CitationMa, Weiwei, Yanan Wu, Xinyue Lin, Liping Yang, and Lili Huang. "Amelioration of Inflammatory Bowel Disease by Bifidobacterium Animalis Subsp. Lactis XLTG11 in Combination with Mesalazine." Frontiers in Microbiology Dec. 2024.
MLA (9th ed.) CitationMa, Weiwei, et al. "Amelioration of Inflammatory Bowel Disease by Bifidobacterium Animalis Subsp. Lactis XLTG11 in Combination with Mesalazine." Frontiers in Microbiology, Dec. 2024.
Warning: These citations may not always be 100% accurate.
